Cannara Biotech Inc. has shown positive momentum this week amidst a backdrop of strategic financial moves.
Cannara Biotech Inc. (LOVE.TO) experienced a notable uptick in its stock price this week, closing at C$2.14, reflecting a 1.85% increase on the day and a 3.77% gain over the week. This performance comes as the company continues to solidify its financial position and expand its operations.
Advertisement
Cannara Biotech Inc.
LOVE.TO
LOVE.TO
Cannara Biotech Inc.
WealthAwesomeMarket cap
$213.37M
P/E
19.6x
52W high
$2.37
52W low
$1.55
1W change
+3.77%
Beta
0.36
Analyst Price Targets
Based on analyst covering LOVE · as of Sep 17, 2026
Wall Street analysts forecast LOVE stock price to fall 78.4% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.38
-78.4% Upside
Current Price
C$15.62
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LOVE's historical volatility
30-Day Vol
20.4%
Annualized
90-Day Vol
30.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.63
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.33 | C$2.18 – C$2.51 |
| 60 trading days | C$2.48 | C$2.24 – C$2.74 |
| 90 trading days | C$2.63 | C$2.33 – C$2.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find Cannara Biotech's recent financial maneuvers and its steady growth trajectory appealing, especially in the context of its strategic partnerships and credit facility expansion.
Cannara Biotech Inc. Reports 19.57% YTD Growth
The company's stock has seen a year-to-date increase of 19.57%, indicating strong performance relative to its historical figures.
Bull case
The recent announcement of an expanded $80 million credit facility supports Cannara's growth initiatives and enhances its financial flexibility. This move could position the company well for further market expansion.
Bear case
Despite these positive developments, Cannara's stock remains vulnerable to market volatility and operational challenges within the competitive cannabis industry.
Recent Price Action
Cannara Biotech Inc. (LOVE.TO) closed at C$2.14 this week, reflecting a 1.85% increase on the day and a 3.77% rise over the week. Over the past month, the stock has appreciated by 10.55%, and year-to-date, it has grown by 19.57%, showcasing a solid upward trend.
Company News and Catalysts
Advertisement
This week, Cannara Biotech announced an expanded $80 million syndicated credit facility with BMO and TD Bank, aimed at enhancing its financial flexibility and supporting growth initiatives. This strategic move follows a series of positive financial reports, including record revenues and profitability in previous quarters, positioning the company favorably in the cannabis market.
Technical Picture
From a technical standpoint, Cannara's stock is trading above both its 50-day moving average of C$1.97 and its 200-day moving average of C$1.83, indicating a bullish trend. The stock's 52-week range is C$1.55 to C$2.37, with the current price at approximately 72% of this range. With a beta of 0.36, Cannara's stock demonstrates lower volatility compared to the market, which may appeal to conservative investors. However, the recent trading volume of 21,304 shares is significantly below the 20-day average volume of 52,119 shares, suggesting lower market activity.
Insider Activity
Currently, there is no significant insider activity reported for Cannara Biotech Inc. that would influence market perception.
Price Action Summary
In summary, Cannara Biotech Inc. closed at C$2.14, reflecting a 1D increase of 1.85%. The stock continues to show potential for growth as it navigates the evolving cannabis sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
